Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma

被引:19
作者
Luk, JM
Su, YCF
Lam, SCT
Lee, CK
Hu, MY
He, QY
Lau, GK
Wong, FWS
Fan, ST
机构
[1] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Ctr Study Liver Dis, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Ctr Study Liver Dis, Dept Med, Hong Kong, Hong Kong, Peoples R China
[5] Fudan Univ, Zhongshan Hosp, Expt Res Ctr, Shanghai 200433, Peoples R China
[6] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore
关键词
hepatocellular carcinoma; Ku autoantigen; monoclonal antibody; tumor marker;
D O I
10.1002/pmic.200401084
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A murine monoclonal antibody (mAb), CLD3 (IgG(1),kappa), was generated against hepatocellular carcinoma (HCC). Both immunofluorescence and immunohistochemical assays indicated the reactivity of CLD3 mAb localized at the nucleus and/or cytoplasm of tumorigenic HCC cell lines as well as in liver cancer tissues. By immunoprecipitation and using the matrix-assisted laser desorption/ionization-time of flight mass spectrometry approach, the antigenic specificity of CLD3 was determined to be heterodimeric Ku70 and Ku80 autoantigen, which was confirmed by Western blotting.
引用
收藏
页码:1980 / 1986
页数:7
相关论文
共 32 条
[1]   Autoantigen Ku in the brain. Developmentally regulated expression and subcellular localization [J].
Bakalkin, G ;
Yakovleva, T ;
Hurd, YL ;
Nussenzweig, A ;
Li, GC ;
Terenius, L .
NEUROREPORT, 1998, 9 (09) :2147-2151
[2]   ANTIGENIC CHARACTERIZATION OF HUMAN HEPATOCELLULAR-CARCINOMA - DEVELOPMENT OF INVITRO AND INVIVO IMMUNOASSAYS THAT USE MONOCLONAL-ANTIBODIES [J].
CARLSON, RI ;
BENPORATH, E ;
SHOUVAL, D ;
STRAUSS, W ;
ISSELBACHER, KJ ;
WANDS, JR .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :40-51
[3]  
Fewell JW, 1996, J CELL SCI, V109, P1937
[4]  
FUHRER JP, 1991, CANCER RES, V51, P2158
[5]   MONOCLONAL-ANTIBODIES IN CANCER-DETECTION AND THERAPY [J].
GOLDENBERG, DM .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03) :297-312
[6]   ESTABLISHMENT OF AN ENZYME-IMMUNOASSAY USING MONOCLONAL-ANTIBODY (HG1-219) AND ITS APPLICATION FOR THE DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA [J].
HADA, T ;
KINOSHITA, Y ;
ICHIMORI, Y ;
IMANISHI, H ;
UMEYAMA, K ;
AMURO, Y ;
TOYOSAKA, A ;
OKAMOTO, E ;
HIGASHINO, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (12) :1366-1372
[7]   Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis [J].
Hochleitner, EO ;
Borchers, C ;
Parker, C ;
Bienstock, RJ ;
Tomer, KB .
PROTEIN SCIENCE, 2000, 9 (03) :487-496
[8]   MONOCLONAL-ANTIBODIES AGAINST ANTIGENS EXPRESSED ON HUMAN HEPATOCELLULAR-CARCINOMA CELLS [J].
HU, CP ;
HAN, SH ;
LUI, WY ;
HSU, HC ;
LIN, YM ;
LIN, PH ;
CHEN, LR ;
HSIEH, HG ;
KUO, PT ;
PENG, FK ;
CHANG, CM .
HEPATOLOGY, 1986, 6 (06) :1396-1402
[9]   Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis [J].
Huguet, S ;
Labas, V ;
Duclos-Vallee, JC ;
Bruneel, A ;
Vinh, J ;
Samuel, D ;
Johanet, C ;
Ballot, E .
PROTEOMICS, 2004, 4 (05) :1341-1345
[10]   A comprehensive approach for establishment of the platform to analyze functions of KIAA proteins: Generation and evaluation of anti-mKIAA antibodies [J].
Koga, H ;
Shimada, K ;
Hara, Y ;
Nagan, M ;
Kohga, H ;
Yokoyama, R ;
Kimura, Y ;
Yuasa, S ;
Magae, J ;
Inamoto, S ;
Okazaki, N ;
Ohara, O .
PROTEOMICS, 2004, 4 (05) :1412-1416